Senior Manager, Market Development, EMEAI Human Disease

This role focuses on identifying and unlocking new customer segments, applications, and geographies, translating ONT’s unique sequencing capabilities into scalable, commercially impactful market opportunities. Working at the intersection of science, policy, and commercial strategy, this role partners closely with sales, marketing, product, medical, regulatory, and government affairs teams to accelerate adoption and long‑term revenue growth.

This role has a primary focus on high-value applications in Human Disease and where Oxford Nanopore Technologies offers clear differentiation. The role will identify and validate priority market opportunities, develop strategic partnerships and evidence-generation programs, and support the progression of promising applications from research-stage use through operationalization and production-scale deployment.

This role is suited to a highly self‑directed builder who thrives in ambiguous environments and can create momentum ahead of fully scaled organizational infrastructure.

Key Responsibilities and Duties:

Market Expansion & Growth

Identify, assess, and validate new market opportunities for ONT technologies across research, applied, and clinical customer segments.

Develop and execute commercial‑forward market development strategies with clear milestones and measurable growth outcomes.

Expand market access by enabling entry into new customer segments and geographies across EMEAI.

Provide structured input into future product, workflow, and portfolio roadmaps based on market needs and evidence gaps.

Partnerships, KOL & Ecosystem Development

Develop strategic partnerships and collaborations to enable entry across Human Disease, including new applications.

Build, engage, and develop Key Opinion Leaders (KOLs) and influencer networks aligned to ONT growth priorities.

Lead community advocacy, education, and awareness initiatives to support market creation and adoption.

Partner with academic, clinical, industry, and government stakeholders to strengthen ONT’s ecosystem presence.

Evidence Generation & Standards Shaping

Define and execute evidence generation strategies, including gap analysis to support market entry for Human Disease.

Support development of scientific, clinical, and economic proof points that enable adoption and scale.

Partner with thought leaders to influence professional societies, guidelines, and standards that maximize the impact of ONT technology.

Translate evidence into compelling commercial and value‑based narratives for customers and stakeholders.

Clinical, Regulatory & Market Access Alignment

Support regulatory, reimbursement, and market access pathways when entering or expanding clinical markets by applying knowledge of the region, leverage society engagement and standards.

Work closely with regulatory, medical, and government affairs teams (where established), to align market development activities with policy and compliance requirements, being the key conduit with the customer in region and these teams to ensure clear objective are achieved and programs delivered.

Enable customers operating in both regulated and unregulated environments through education and strategic guidance.

Commercial Enablement & Cross‑Functional Leadership

Partner with regional commercial teams to support pipeline development, strategic deals, and complex opportunities.

Enable sales and marketing teams through education, positioning, and strategic content tailored to Human Disease.

Communicate market intelligence and customer insights to inform commercial strategy and execution.

Operate effectively within a global, matrixed organization, influencing across functions and seniority levels.

Leadership & Capability Development

Provide leadership and strategic direction to market development activities across EMEAI.

Support capability building through training, coaching, and knowledge transfer.

Foster collaboration, accountability, and execution discipline across cross‑functional teams.

Drive cross‑regional alignment and knowledge‑sharing, partnering with global Market Development leaders across AMR, EMEAI and APAC to ensure consistency of strategy, prioritisation, and execution as the global capability scales.

Act as an early builder for the global Market Development function, contributing learnings, frameworks, and operating models that inform future role expansion across regions.

Advanced degree (or equivalent experience) in genomics, molecular biology, life sciences or a related discipline.

Strong understanding of clinical, research, and applied genomics ecosystems in EMEAI with a strong personal network across these areas and the ability to independently open doors and create opportunities.

Extensive experience in genomics, life sciences, or healthcare technology, with strong exposure to commercial strategy and market development.

Shown success in creating or expanding markets, launching new collaborations and evidence generation studies, or enabling adoption of innovative technologies.

Demonstrated experience in society engagement, white paper creation and participating/driving standards setting.

Proven ability to influence senior stakeholders and operate effectively in complex, matrixed environments.

Demonstrated ability to operate effectively in lean or emerging organizational environments, building capability and momentum without reliance on established support functions.

Hands‑on mindset, with willingness to contribute directly to content development, stakeholder education, and early market‑shaping activities.

High resilience and adaptability, with the ability to progress initiatives even when cross‑functional resources are limited or evolving.

Please note that no terminology in this advert is intended to discriminate on the grounds of a person's gender, marital status, race, religion, colour, age, disability or sexual orientation. Every candidate will be assessed only in accordance with their merits, qualifications and abilities to perform the duties of the job.

#LI-JR1

#LI-hybrid

Oxford Nanopore Technologies: Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments. With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries.